Evidence map›Paper›PMID 28087714›Full record

ArticleGenes & development2016

DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2.

Julian Kwan, Anna Sczaniecka, Emad Heidary Arash, Liem Nguyen, Chia-Chun Chen, Srdjana Ratkovic, Olga Klezovitch, Liliana Attisano, Helen McNeill, Andrew Emili and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Targeting the Hippo pathway in cancer.Nature reviews. Drug discovery · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Julian KwanDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Anna SczanieckaDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Emad Heidary ArashDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Liem NguyenDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Chia-Chun ChenDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Srdjana RatkovicDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Olga KlezovitchDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Liliana AttisanoDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Helen McNeillDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Andrew EmiliDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
Valeri VasioukhinDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Fred Hutch Cancer Center · USUniversity of Toronto · CALunenfeld-Tanenbaum Research Institute · CAUniversity of Washington · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
Alpha-Catenin in Regulation of Tissue Homeostasis and CancerR01CA179914 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VASIOUKHIN, VALERI · 2014 to 2018
$2.2M
Regulation of Hippo Signaling by Src-Family KinasesR01CA188452 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VASIOUKHIN, VALERI · 2014 to 2018
$1.8M
Cell Polarity in Self-renewal and Differentiation of Stem/Progenitor CellsR01CA131047 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VASIOUKHIN, VALERI · 2009 to 2012
$1.4M
CIHR MOP-133431NCI NIH HHS R01 CA131047NCI NIH HHS R01 CA179914NCI NIH HHS R01 CA188452NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

Disruption of apical-basal polarity is implicated in developmental disorders and cancer; however, the mechanisms connecting cell polarity proteins with intracellular signaling pathways are largely unknown. We determined previously that membrane-associated guanylate kinase (MAGUK) protein discs large homolog 5 (DLG5) functions in cell polarity and regulates cellular proliferation and differentiation via undefined mechanisms. We report here that DLG5 functions as an evolutionarily conserved scaffold and negative regulator of Hippo signaling, which controls organ size through the modulation of cell proliferation and differentiation. Affinity purification/mass spectrometry revealed a critical role of DLG5 in the formation of protein assemblies containing core Hippo kinases mammalian ste20 homologs 1/2 (MST1/2) and Par-1 polarity proteins microtubule affinity-regulating kinases 1/2/3 (MARK1/2/3). Consistent with this finding, Hippo signaling is markedly hyperactive in mammalian Dlg5

Indexed as

AnimalsCell PolarityCells, CulturedDrosophilaGene DeletionGene Expression Regulation, DevelopmentalGene Knockdown TechniquesHEK293 CellsHumansMembrane ProteinsMiceMice, KnockoutProtein BindingProtein DomainsProtein Serine-Threonine KinasesProteomicsDLG5 protein, humanMembrane ProteinsProtein Serine-Threonine KinasesTumor Suppressor Proteinscell polarityDrosophila developmentfunctional proteomicsHippo signalinginteraction networkmammalian developmentprotein complex

Identifiers

PMID28087714
PMCPMC5238729
OpenAlexW2573374261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.